Bruce W. Bode

27.9k citations
273 papers · 21.7k · 16 hit papers · h-index 75

Impact in

    • Diabetes Management and Research
    • Diabetes Treatment and Management
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients
    • Diabetes Management and Education
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Pharmacology and Obesity Treatment

Papers in

    • Diabetes Management and Research 207
    • Diabetes Treatment and Management 55
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 7
    • Diabetes and associated disorders 14

Bruce W. Bode

264 papers receiving 20.1k citations

Bruce W. Bode's Hit Papers

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial 2023 · 559 citations
5590+4+8Years since publication4008001.2k

Peers

Bruce W. Bode
Comparison fields: 5 of 152
  • Endocrinology, Diabetes and Metabolism 17.1k
  • Pharmacology 867
  • Health Informatics 93
  • Genetics 1.1k
  • Nephrology 263
Replace J. Hans DeVries with:
J. Hans DeVries Netherlands
Satish K. Garg United States
Tadej Battelino Slovenia
Éric Renard France
Dı́dac Mauricio Spain
David M. Maahs United States
Moshe Phillip Israel
Banshi Saboo India
David Kerr United Kingdom
Linong Ji China
Bruce W. Bode relative to J. Hans DeVries Netherlands J. Hans DeVries's profile →
Citations per field
00.5×2×3×3.9×
J. Hans DeVries · 1×
Citations per year

Countries citing papers authored by Bruce W. Bode

Since Specialization
Citations

This map shows the geographic impact of Bruce W. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Bode more than expected).

Fields of papers citing papers by Bruce W. Bode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Bode. The network helps show where Bruce W. Bode may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce W. Bode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce W. Bode Line = papers co-authored together Bruce W. Bode links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20181445
2
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
Hit paper breakdown →
2015938
3
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Hit paper breakdown →
2008913
4
Exercise management in type 1 diabetes: a consensus statement
Hit paper breakdown →
2017659
5
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Hit paper breakdown →
2015566
6
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Hit paper breakdown →
2023559
7
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Hit paper breakdown →
2020558
8
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
Hit paper breakdown →
2016506
9
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
Hit paper breakdown →
2013501
10
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
Hit paper breakdown →
2017475
11 2005458
12 2011415
13 2012325
14 2014307
15 2012286
16
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes
Hit paper breakdown →
2020286
17
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
Hit paper breakdown →
2019275
18 2017272
19 2014268
20 2016265

About Bruce W. Bode

Bruce W. Bode is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Physiology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 273 papers that have together received 21.7k indexed citations. Recurring topics across this work include Diabetes Management and Research (207 papers), Diabetes Treatment and Management (55 papers), Diabetes and associated disorders (14 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers), Clinical Laboratory Practices and Quality Control (3 papers), Pharmacology and Obesity Treatment (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Retinal Imaging and Analysis (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (17.1k citations), Pharmacology (867 citations), Health Informatics (93 citations), Genetics (1.1k citations) and Nephrology (263 citations). Bruce W. Bode has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Satish K. Garg, Richard M. Bergenstal, Paul C. Davidson, Timothy Silleck Bailey, R. Dennis Steed, FRANCINE RATNER KAUFMAN, Irl B. Hirsch, William V. Tamborlane, Robert E. Ratner and Alan J. Garber. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes Care, Diabetes, Diabetes Obesity and Metabolism and Endocrine Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact